DETAILED NOTES ON NORFLUAZEPAM

LC–PDA–MS Evaluation of sheet B; PDA chromatogram a, TIC b, and UV spectra of peak 2 c and of peak 2b d, and ESI mass spectra of peak 2 e and of peak 2b fLittle or no information exists concerning the pharmacological properties, metabolism, and toxicity of 1cP-MiPLA. Though it is commonly characterised by customers as becoming generally additio